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The histone H3 lysine 27 (H3K27) methyltransferase EZH2 is essential for stem cell maintenance and prolifer-
ation. Recent insights suggest that the cyclin-dependent kinase CDK1 phosphorylates EZH2 at specific thre-
onine residues by sensing developmental cues to mediate self-renewal or differentiation during G2/M phase.Generation and maintenance of tissues,
even cancerous tissues, require a contin-
uous supply of differentiated cells from
stem cells or progenitor cells. This supply
is substantially aided by expansion of
a differentiating cell pool to maintain tissue
size or cancerous outgrowth. Such coinci-
dence of proliferation and differentiation
could be symbolized by asymmetric cell
division in various stem cells of inverte-
brates, in which self-renewal and differenti-
ation occur concurrently in extreme cases.
In other words, in one daughter cell, stem
cell properties are retained (memorized),
while in another, they are erased and
rewritten tosomeextent.Cell cycleprogres-
sion has been considered to be a key
process in regulating theepigeneticbalance
between self-renewal and differentiation
of stem/progenitor cells. However, the
detailed mechanism by which this is
achieved remains largely unclear.
The polycomb group (PcG) protein
enhancer of zeste homolog 2 (EZH2)
mediates gene silencing by catalyzing
histone H3 lysine 27 trimethylation
(H3K27me3) (Cao et al., 2002). Rapidly
dividing cells such as cancer cells and
stem cells exhibit robust EZH2 expression
and H3K27me3 enrichment. Conversely,
decreasing EZH2 function is associated
with induction of differentiation within
a progenitor cell pool (Ezhkova et al.,
2009). This suggests that EZH2 activity
could be mediated by specific develop-
mental cues in stem cells and differenti-
ating cells. New findings reported in
several recent papers have shed light on
this question (Chen et al., 2010; Kaneko
et al., 2010; Wei et al., 2011).
Chen et al. (2010) report that cyclin-
dependent kinases CDK1 and CDK2
phosphorylate Thr350 of EZH2 in an
evolutionarily conservedmotif. This modi-fication is important for recruitment of
EZH2 and maintenance of H3K27me3 at
target loci including the HOX, FOX, SOX,
LHX, and TBX gene families. Ablation of
Thr350 phosphorylation by substituting
the threonine residue with an alanine
(T350A) disrupts EZH2 binding and depo-
sition of H3K27me3 at the HOXA9 and
DAB2IP loci and induces global derepres-
sion of genes. Thr350 phosphorylation
is also required for cell proliferation
and migration. These findings have been
reconfirmed by another paper performed
on the murine Ezh2 protein (Kaneko
et al., 2010). This study shows that Cdk1
phosphorylates Thr345 of Ezh2 (counter-
part of Thr350 for human EZH2) specifi-
cally during the G2/M phase of the cell
cycle. Thr345 is located between the
twin DNA binding motifs of Ezh2 and
indeed phosphorylation of this residue
enhances Ezh2 loading and H3K27 trime-
thylation at target genes. Phosphorylation
of Thr345 also promotes Ezh2 binding
to noncoding RNAs (ncRNAs) HOTAIR
and Xist. This observation is particularly
important because it is thought that
ncRNAs play a crucial role in recruitment
of PcG factors to target loci (Khalil et al.,
2009).
Both of these studies observed that
there is another CDK phosphorylation
site at the C terminus of the EZH2 mole-
cule (Thr487 for murine EZh2 and Thr492
for human EZH2), but could not find any
correlation of this modification with
EZH2 loading at its target genes (Chen
et al., 2010; Kaneko et al., 2010). The
paper by Wei et al. (2011) addresses this
point. They show that phosphorylation of
Thr487 (Thr492 in Chen et al., 2010) is
mediated by CDK1 and has a negative
impact on the histone methyltransferase
(HMTase) activity of EZH2 because itDevelopmental Celldisrupts the interaction with other PcG
proteins, SUZ12 and EED, that contribute
to Polycomb repressive complex 2
(PRC2) (Wei et al., 2011). The Thr487
residue is located inside the SUZ12
recognition motif of EZH2; modification
of this site could potentially interfere with
binding to other PRC2 factors. Thr487
phosphorylation also blocks physiological
functions of EZH2 such as cancer cell
invasion and promotes mesenchymal
stem cell differentiation.
A complex picture begins to emerge
from these findings, in which phosphory-
lation of Thr350 acts as a positive signal
to upregulate EZH2 functions such as
stem cell proliferation/maintenance
(Chen et al., 2010; Kaneko et al., 2010),
whereas modification of Thr487 triggers
a block in EZH2 activity leading to cellular
differentiation (Wei et al., 2011). Impor-
tantly, these studies link the G2/M-
specific kinase CDK1 with dynamic
cellular regulation of EZH2. Indeed,
a role for CDK1/2 in human embryonic
stem cells has been recently shown (Van
Hoof et al., 2009). Furthermore, similar to
EZH2, CDK1 activity is positively linked
with cell proliferation and cancer (re-
viewed in Malumbres and Barbacid,
2009) and negatively associated with
cellular differentiation (Ullah et al., 2008).
These insights suggest that CDK1/EZH2
interactions could integrate develop-
mental cues and cell cycle activity to
control self-renewal or differentiation.
Supporting this notion, it has been shown
that upon induction of BMP-mediated
differentiation in embryonic stem cells,
CDK1/2 quickly (60 min) induces a large
number of phosphorylation events to
initiate a wide range of downstream
developmental cascades (see schematic
Figure 1; Van Hoof et al., 2009).20, January 18, 2011 ª2011 Elsevier Inc. 5
Figure 1. Two Phosphorylation Sites on EZH2
Differentially Regulate PRC2
TheG2/Mspecificcyclin-dependent kinaseCDK1 recognizes
developmental cues for self-renewal or differentiation and
phosphorylates thehistoneH3 lysine27 (H3K27)methyltrans-
ferase EZH2 at Thr350 (Thr345 for mouse) or Thr487, respec-
tively. The Thr350 modification increases/stabilizes the
binding of noncoding RNAs and promotes EZH2 recruitment
into target loci. Conversely, phosphorylation of Thr487 blocks
EZH2activity anddeposition of H3K27 trimethylationby inter-
fering with PRC2 complex formation.
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question that we need to address in
the near future. How does CDK1
distinguish between the cellular cues
for stem cell self-renewal and differ-
entiation? One simple explanation
could be that the presentation of
EZH2 to CDK1 is differentially regu-
latedbyother inputs. In a cellular envi-
ronment that promotes self-renewal,
the Thr350 residue could be exposed
to CDK1, while the Thr487 could be
masked by other PRC2 components
such as SUZ12 and EED. Alterna-
tively, in differentiating cells, EZH2
could be prevented from binding
ncRNAs, in which case physical inter-
actions with other PRC2 partners
could be attenuated, unmasking the
C-terminal Thr487 site to CDK1.
Could both Thr350 and Thr487 phos-
phorylated states of EZH2 exist within
a particular cell population? Kaneko
et al. (2010) find that only a small
percentage of cells are phosphory-
lated at any of these residues (1%
and 3% for Thr345 and Thr487,
respectively). However, it is unclear
whether the balance between these
populations could affect the develop-
mental state within a cell pool.
Furthermore, CDK1/2 might phos-
phorylate other PcG factors/interac-tors such as JARID2, WEE1, and USP7
(Van Hoof et al., 2009). Therefore, epige-
netic regulation of cell fate by CDK1 could
be linked with a broader spectrum of PcG
proteins, apart from EZH2. Future studies
are necessary to fully elucidate these
questions.
Whatever the precise mechanisms
are, posttranslational modifications of
key chromatin regulators during the6 Developmental Cell 20, January 18, 2011 ªG2/M phase appear to be a critical
pathway to control cell fate during self-
renewal and development. The molec-
ular networks that control entry, promo-
tion, and exit from the G2/M phase have
been extensively analyzed for the last
several decades. The findings from
these studies indeed point out to a link
with differentiation and development (re-
viewed in Budirahardja and Go¨nczy,2011 Elsevier Inc.2009). We may revisit these mecha-
nisms to envision how epigenetic
mechanisms interpret various envi-
ronmental cues.REFERENCE
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